Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.
Ge Z, Song C, Ding Y, Tan BH, Desai D, Sharma A, Gowda R, Yue F, Huang S, Spiegelman V, Payne JL, Reeves ME, Iyer S, Dhanyamraju PK, Imamura Y, Bogush D, Bamme Y, Yang Y, Soliman M, Kane S, Dovat E, Schramm J, Hu T, McGrath M, Chroneos ZC, Payne KJ, Gowda C, Dovat S.
Ge Z, et al. Among authors: hu t.
Leukemia. 2021 May;35(5):1267-1278. doi: 10.1038/s41375-021-01132-5. Epub 2021 Feb 2.
Leukemia. 2021.
PMID: 33531656
Free PMC article.